Neumora insider Singh sells 277,773 shares after option exercise
Neumora Therapeutics, Inc. (NMRA) reported insider transactions by Chief Operating and Development Officer Aurora Daljit Singh over August 17–19, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Neumora Therapeutics, Inc. (NMRA) reported insider transactions by Chief Operating and Development Officer Aurora Daljit Singh over August 17–19, 2026. Singh exercised stock options at an exercise price of $0.72 per share for a total of 243,753 shares of common stock and reported 277,773 shares sold in open-market transactions at weighted average prices within ranges running from about $1.46 to $1.70 per share. Some transactions involved shares held indirectly through the Aurora Family Trust, whose beneficiaries are members of Singh’s immediate family.
Insights
Analyzing...
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
29 txns
Insider
Aurora Daljit Singh
Role
See Remarks
Sold
277,773 shs ($432K)
Approx. gross sale proceeds
$432K
Approx. exercise cost
$176K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F7 | 13,268 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F13 | 17,732 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F5, F3 | 30,918 | $0.00 | $0.00 |
| Exercise | Common Stock | 13,268 | $0.72 | $10K |
| Exercise | Common Stock | 17,732 | $0.72 | $13K |
| Sale | Common Stock F11 | 31,000 | $1.6461 | $51K |
| Exercise | Common Stock F3 | 30,918 | $0.72 | $22K |
| Sale | Common Stock F12, F3 | 30,918 | $1.6459 | $51K |
| Exercise | Stock Option (Right to Buy) F7 | 34,162 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F5, F3 | 34,987 | $0.00 | $0.00 |
| Exercise | Common Stock | 34,162 | $0.72 | $25K |
| Sale | Common Stock F9 | 34,162 | $1.5847 | $54K |
| Exercise | Common Stock F3 | 34,987 | $0.72 | $25K |
| Sale | Common Stock F10, F3 | 34,987 | $1.5859 | $55K |
| Exercise | Stock Option (Right to Buy) F5 | 40,890 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F6 | 15,355 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F7 | 1,424 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F8 | 1 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F5, F3 | 25,279 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F5, F3 | 29,737 | $0.00 | $0.00 |
| Exercise | Common Stock | 40,890 | $0.72 | $29K |
| Exercise | Common Stock | 15,355 | $0.72 | $11K |
| Exercise | Common Stock | 1,424 | $0.72 | $1K |
| Exercise | Common Stock | 1 | $0.72 | $0.72 |
| Sale | Common Stock F1 | 57,670 | $1.5055 | $87K |
| Sale | Common Stock F2 | 34,020 | $1.4853 | $51K |
| Exercise | Common Stock F3 | 25,279 | $0.72 | $18K |
| Exercise | Common Stock F3 | 29,737 | $0.72 | $21K |
| Sale | Common Stock F4, F3 | 55,016 | $1.5047 | $83K |
Holdings After Transaction:
Stock Option (Right to Buy) — 1,393,180 contracts (Direct);
Stock Option (Right to Buy) — 45,026 contracts (Indirect, See footnote);
Common Stock — 48,750 shares (Direct);
Common Stock — 0 shares (Indirect, See footnote)
Footnotes (13)
- F1. This transaction was executed in multiple trades at prices ranging from $1.46 to $1.555, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F2. This transaction was executed in multiple trades at prices ranging from $1.46 to $1.5277, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F3. Shares held by Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries.
- F4. This transaction was executed in multiple trades at prices ranging from $1.46 to $1.555, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F5. The stock option is fully vested and exercisable.
- F6. 25% of the shares subject to the option vest on the first anniversary measured from February 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- F7. 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- F8. 25% of the shares subject to the option vest on the first anniversary measured from February 13, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- F9. This transaction was executed in multiple trades at prices ranging from $1.49 to $1.645, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F10. This transaction was executed in multiple trades at prices ranging from $1.48 to $1.65, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F11. This transaction was executed in multiple trades at prices ranging from $1.62 to $1.6995, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F12. This transaction was executed in multiple trades at prices ranging from $1.62 to $1.7006, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F13. 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Key Figures
Total shares sold: 277,773 shares
Total shares from option exercises: 243,753 shares
Option exercise price: $0.72 per share
+4 more
7 metrics
Total shares sold
277,773 shares
Aggregate open-market sales reported in transactionSummary
Total shares from option exercises
243,753 shares
Aggregate derivative exercises (M) reported in transactionSummary
Option exercise price
$0.72 per share
Conversion or exercise price for stock options exercised
Direct sale example price
$1.5055 per share
Weighted average price for 57,670-share direct sale on 2026-08-17
Indirect sale example price
$1.5047 per share
Weighted average price for 55,016-share indirect sale on 2026-08-17
Number of sale transactions
7
Non-derivative transactions coded S in transactionSummary
Number of option exercises
11
Derivative transactions coded M in transactionSummary
Key Terms
stock option, weighted average sale price, indirect ownership, Aurora Family Trust, +1 more
5 terms
stock option financial
"The security title is listed as "Stock Option (Right to Buy)" in several rows"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
weighted average sale price financial
"Footnotes state the price reflects the weighted average sale price for multiple trades"
indirect ownership financial
"Certain transactions show ownership type as indirect with nature "See footnote""
Aurora Family Trust financial
"A footnote explains shares held by Aurora Family Trust for immediate family beneficiaries"
vesting commencement date financial
"Footnotes describe options vesting based on a specified Vesting Commencement Date"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did NMRA report for Aurora Daljit Singh on this Form 4?
Aurora Daljit Singh reported mixed activity, exercising stock options and selling common shares. From August 17–19, 2026, Singh exercised options into 243,753 NMRA shares and reported open-market sales totaling 277,773 shares at weighted average prices within stated ranges.
How many NMRA stock options did Aurora Daljit Singh exercise and at what price?
Aurora Daljit Singh exercised options covering 243,753 NMRA shares at an exercise price of $0.72 per share. These exercises, coded as derivative transactions (M), converted stock options into common stock over the three trading days reported in the Form 4.
Were any of Aurora Daljit Singh’s NMRA transactions made through a trust?
Yes. Some transactions involve shares held by the Aurora Family Trust. A footnote states that members of Singh’s immediate family are the sole beneficiaries of this trust, and certain option exercises and share sales are reported as indirect ownership through it.
AI-generated analysis. How Rhea-AI works. Not financial advice.
